Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

SELL
$58.92 - $84.67 $1.69 Million - $2.43 Million
-28,690 Reduced 60.94%
18,390 $1.14 Million
Q2 2022

Aug 09, 2022

BUY
$79.4 - $116.36 $801,940 - $1.18 Million
10,100 Added 27.31%
47,080 $3.76 Million
Q1 2022

Apr 29, 2022

BUY
$86.42 - $109.81 $3.2 Million - $4.06 Million
36,980 New
36,980 $3.89 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Cozad Asset Management Inc Portfolio

Follow Cozad Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cozad Asset Management Inc with notifications on news.